Amlodipine 10mg

DRUG6 trials

Sponsors

HK inno.N Corporation, Chong Kun Dang Pharmaceutical, Shin Poong Pharmaceutical Co. Ltd., Korea University Guro Hospital

Conditions

Essential HypertensionHypertension

Phase 1

CKD-330 Drug-Drug Interaction Study (Amlodipine)

CompletedNCT02064556

Chong Kun Dang PharmaceuticalHypertension

Start: 2014-05-31End: 2014-07-31Updated: 2014-08-15

Phase 2

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

HK inno.N CorporationEssential Hypertension

Start: 2014-02-28End: 2015-12-31Target: 384Updated: 2014-04-30

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Chong Kun Dang PharmaceuticalEssential Hypertension

Start: 2014-03-31End: 2015-06-30Target: 456Updated: 2015-03-30

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

CompletedNCT02944734

Shin Poong Pharmaceutical Co. Ltd.Essential Hypertension

Start: 2014-09-30End: 2015-12-31Updated: 2016-11-22

Phase 3

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

CompletedNCT02651870

Chong Kun Dang PharmaceuticalHypertension

Start: 2015-04-22End: 2016-02-29Updated: 2020-08-25

Phase 4

Manidipine Versus Amlodipine in Patients With Hypertension

TerminatedNCT03106597

Korea University Guro HospitalHypertension

Start: 2015-08-20End: 2019-08-14Updated: 2020-09-04

Related Papers

Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.

2017-07-1910 citations